Umbrex is pleased to welcome Samuel Alan Cooper. Sam has spent the majority of his career in the consulting space, but as an IT consultant and a management consultant. He began his career in the Big Data & Analytics space, supporting clients across the operational chain from data ingestion, warehousing, manipulation, and visualization. Receiving his […]
Sanjay Gandhi shares an article that discusses strategies for companies and High Net Worth families and individuals that can provide a silver lining amidst the tough news and provide long-term benefits when valuations rise again. The coronavirus (COVID-19) has resulted in significant public market losses, as reflected in daily stock market gyrations and volatility. Private […]
Kaihan Krippendorff provides insight into the rising valuations of tech stocks and attributed the rise of cryptocurrencies, and NFTs (non-fungible tokens). It’s been a while since Saturday Night Live was a staple of Monday morning conversation, but this week as our team gathered around the Zoom screen to join our check-in call, the sketch […]
Jeff Perry shares a post that identifies the positive potential of divestitures in a company’s growth portfolio. Houston, do we have a problem? While many companies talk about the need to regularly reshape its portfolio, divestitures are too often considered aborted missions. Quite the contrary, divestitures can be rocket fuel for other business priorities […]
Umbrex is pleased to welcome Rodolphe Lebrun with LDP Partner. Rodolphe Lebrun is an advisor and interim executive for biotech, medtech and biopharma. He spent 5 years at McKinsey focusing on Life Sciences and led commercial excellence at AbbVie Belgium for 2 years. Prior to McKinsey, he was a R&D project manager in aerospace within […]
